摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxyacridin-9-ylamino)-propyl]-propane-1,3-diamine | 57735-82-7

中文名称
——
中文别名
——
英文名称
N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxyacridin-9-ylamino)-propyl]-propane-1,3-diamine
英文别名
1,9-Bis-(2-methoxy-6-chlor-9-acridinyl)-1,5,9-triazanonan;1,3-Propanediamine, N-(6-chloro-2-methoxy-9-acridinyl)-N'-(3-((6-chloro-2-methoxy-9-acridinyl)amino)propyl)-;N'-(6-chloro-2-methoxyacridin-9-yl)-N-[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propyl]propane-1,3-diamine
N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxyacridin-9-ylamino)-propyl]-propane-1,3-diamine化学式
CAS
57735-82-7
化学式
C34H33Cl2N5O2
mdl
——
分子量
614.574
InChiKey
JXKNOHCXCIJXLN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    157-159 °C
  • 沸点:
    840.0±65.0 °C(Predicted)
  • 密度:
    1.339±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.8
  • 重原子数:
    43
  • 可旋转键数:
    12
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    80.3
  • 氢给体数:
    3
  • 氢受体数:
    7

SDS

SDS:7bf136932c6675be7d12e5a08ec69fdf
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxyacridin-9-ylamino)-propyl]-propane-1,3-diamineN,N-二异丙基乙胺 、 bromo-tris(1-pyrrolidinyl)phosphonium hexafluorophosphate 、 三氟乙酸 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 生成 2-amino-N,N-bis[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propyl]propanamide
    参考文献:
    名称:
    Antimalarial, Antitrypanosomal, and Antileishmanial Activities and Cytotoxicity of Bis(9-amino-6-chloro-2-methoxyacridines):  Influence of the Linker
    摘要:
    Forty bis(9-amino-6-chloro-2-methoxyacridines), in which acridine moieties are joined by alkanediamines, polyamines, or polyamines substituted by a side chain, were synthesized and tested for their in vitro activity upon the erythrocytic stage of Plasmodium falciparum, trypomastigote stage of Trypanosoma brucei, and amastigote stage of Trypanosoma cruzi and Leishmania infantum as well as for their cytotoxic effects upon MRC-5 cells. Results clearly showed the importance of the nature of the linker and of its side chain for antiparasitic activity, cytotoxicity, and cellular localization. Among several compounds devoid of cytotoxic effects at 25 mu M upon MRC-5 cells, one displayed IC50 values ranging from 8 to 18 nM against different P. falciparum strains while three others totally inhibited T. brucei at 1.56 mu M.
    DOI:
    10.1021/jm990946n
  • 作为产物:
    描述:
    N-(6-Chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxy-acridin-9-ylamino)-propyl]-N'-((4S,5R,4'R)-2,2,2',2'-tetramethyl-[4,4']bi[[1,3]dioxolanyl]-5-ylmethyl)-propane-1,3-diamine 在 溶剂黄146三氟乙酸 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 1.0h, 生成 N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxyacridin-9-ylamino)-propyl]-propane-1,3-diamine
    参考文献:
    名称:
    三胺连接吖啶二聚体的酸催化断裂反应
    摘要:
    描述了从 Nϵ-(2,3,4,5-四羟基戊基)取代的侧链和/或其丙酮化物形式的三胺连接的吖啶二聚体的 C-Nϵ键的酸催化裂解。提出了一种设想的多邻基辅助溶剂分解反应机理。
    DOI:
    10.1002/jccs.200100115
点击查看最新优质反应信息

文献信息

  • Linker-modified triamine-linked acridine dimers: Synthesis and cytotoxicity properties in vitro and in vivo
    作者:Shan-Shue Wang、Yi-Jen Lee、Shih-Chung Hsu、Hsueh-O Chang、Wei-Kung Yin、Lien-Shange Chang、Shan-Yen Chou
    DOI:10.1016/j.bmc.2006.10.054
    日期:2007.1
    preparation and cytotoxicity properties of a series of N(epsilon)-substituted triamine-linked acridine dimers are described. Most acridine dimer derivatives reveal highly potent in vitro cytotoxicity properties and DNA binding activity. Several acridine dimers were selected to study their action in vivo. These acridine dimers have demonstrated a narrow safe margin, as has adriamycin, but higher maximum
    描述了一系列N(ε)取代的三胺连接的a啶二聚体的制备和细胞毒性。大多数a啶二聚体衍生物具有很强的体外细胞毒性和DNA结合活性。选择了几种a啶二聚体以研究其在体内的作用。与阿霉素相比,这些demonstrated啶二聚体已显示出狭窄的安全范围,但与ICR小鼠中的阿霉素相比,其最大耐受剂量(MTD)更高。cr啶二聚体在体内还表现出各种抗anol-COLO 205实体肿瘤活性。化合物1显示出最有效的实体瘤抑制作用。
  • Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy
    申请人:THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    公开号:US10774047B2
    公开(公告)日:2020-09-15
    The invention provides dimeric quinacrine derivatives and related compounds and compositions, methods of treatment and syntheses. The novel compounds exhibit unexpected anticancer activity and are useful in the treatment of a variety of autophagy-related disorders.
    本发明提供了二聚喹啉衍生物和相关化合物及组合物、治疗方法和合成方法。这些新型化合物具有意想不到的抗癌活性,可用于治疗多种自噬相关疾病。
  • Increasing antitumor activity in vivo by enhancing acridine dimer solubility with salt preparations
    作者:Shan-Shue Wang、Yi-Jen Lee、Shih-Chung Hsu、Chen Hsieh、Lien-Shange Chang、Shan-Yen Chou
    DOI:10.1007/s00044-009-9213-9
    日期:2010.7
    The potent activities of many anticancer agents have been demonstrated by in vitro assays. However, their poor solubility may result in diminishing anticancer activities in vivo. Previously, we synthesized a series of bisacridine derivatives shown to be potent in cytotoxicity and DNA intercalating activity in vitro. Initially, the compound 1, (N-(6-chloro-2-methoxy-acridin-9-yl)-N'-[3-(6-chloro-2-methoxy-acridin-9-ylamino)-propyl]-propane-1,3-diamine), is insoluble in polar solvent and does not reveal antihuman COLO 205 solid-tumor activity in vivo. To enhance its solubility, three salt forms (CH(3)COOH, CH(3)SO(3)H, and CF(3)COOH) of compound 1 were synthesized and their solubility was found to be greatly improved compared with that of the free base. Among these salts, the compound 1 center dot A (tris)acetate salt has shown good solubility in H(2)O and 2.5% Cremophor (v/v) and demonstrated anti-COLO205 solid-tumor activity in vivo.
  • ACHSON, R. M.;CONSTABLE, E. C.;WRIGHT, R. G. ,, MCR.;TAYLOR, G. N., J. CHEM. RES. MICROFICHE, 1983, N 1, 2-3
    作者:ACHSON, R. M.、CONSTABLE, E. C.、WRIGHT, R. G. ,, MCR.、TAYLOR, G. N.
    DOI:——
    日期:——
  • DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY
    申请人:The Trustees of The University of Pennsylvania
    公开号:EP3283463B1
    公开(公告)日:2021-01-20
查看更多